← Back to Search

Other

Atopic Dermatitis PF-07038124 0.01% ointment for Atopic Dermatitis

Phase 2
Waitlist Available
Research Sponsored by Pfizer
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up week 1, 2, 4, 6, 8, 10, 12, and follow-up
Awards & highlights

Study Summary

This trialtests safety, effectiveness, and side effects of an ointment for skin application.

Eligible Conditions
  • Atopic Dermatitis
  • Plaque Psoriasis

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~week 1, 2, 4, 6, 8, 10, 12, and follow-up
This trial's timeline: 3 weeks for screening, Varies for treatment, and week 1, 2, 4, 6, 8, 10, 12, and follow-up for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Proportion of participants achieving Investigator's Global Assessment (IGA) score of clear (0) or almost clear (1) (on a 5-point scale) and a reduction from baseline of ≥2 points at Week 12
Proportion of participants achieving Patient Global Assessment (PGA) score of clear (0) or almost clear (1) (on a 5-point scale) and a reduction from baseline of ≥2 points at Week 12
Secondary outcome measures
Change From Baseline in Psoriasis Area and Severity Index (PASI) total score
Incidence of Increase in Local Tolerability Severity Grades
Incidence of Treatment Emergent Adverse Events (AEs) and Serious Adverse Events (SAEs)
+13 more

Trial Design

7Treatment groups
Experimental Treatment
Placebo Group
Group I: Plaque Psoriasis PF-07038124 0.06% ointmentExperimental Treatment1 Intervention
Plaque Psoriasis
Group II: Plaque Psoriasis PF-07038124 0.03% ointmentExperimental Treatment1 Intervention
Plaque Psoriasis
Group III: Plaque Psoriasis PF-07038124 0.01% ointmentExperimental Treatment1 Intervention
Plaque Psoriasis
Group IV: Atopic Dermatitis PF-07038124 0.03% ointmentExperimental Treatment1 Intervention
Atopic Dermatitis
Group V: Atopic Dermatitis PF-07038124 0.01% ointmentExperimental Treatment1 Intervention
Atopic Dermatitis
Group VI: Atopic Dermatitis Vehicle ointmentPlacebo Group1 Intervention
Atopic Dermatitis
Group VII: Plaque Psoriasis Vehicle ointmentPlacebo Group1 Intervention
Plaque Psoriasis
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
PF-07038124 ointment 0.01%
2022
Completed Phase 2
~270
PF-07038124 ointment 0.06%
2022
Completed Phase 2
~270
PF-07038124 ointment 0.03%
2022
Completed Phase 2
~270

Find a Location

Who is running the clinical trial?

PfizerLead Sponsor
4,567 Previous Clinical Trials
10,911,609 Total Patients Enrolled
Pfizer CT.gov Call CenterStudy DirectorPfizer
3,474 Previous Clinical Trials
8,092,777 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many participants are accepted for this medical research project?

"Affirmative. According to clinicaltrials.gov, the current recruitment process for this medical trial was initiated on September 26th 2022 and has been updated as of November 22nd 2022. This study requires 240 patients from 20 different clinical sites."

Answered by AI

Are enrollment opportunities currently available for this trial?

"Indeed, the information hosted on clinicaltrials.gov indicates that this medical trial is enrolling patients and has been since its inception in September 26th 2022. The study's details were last updated November 22nd of the same year."

Answered by AI

Has the FDA sanctioned Plaque Psoriasis PF-07038124 0.06% ointment?

"Taking into account the Phase 2 nature of this trial, our team rated Plaque psoriasis PF-07038124 0.06% ointment's safety as a moderate 2 - due to limited evidence supporting efficacy but some data indicating safety."

Answered by AI

How many Canadian establishments are running this research?

"This clinical trial has 20 recruitment sites including the likes of Wiseman Dermatology Research Inc. in Winnipeg, Skin care Physicians of Georgia in Macon, and Progressive Clinical Research in San Antonio. The other 17 locations are equally as established."

Answered by AI

What is the purpose of this research endeavor?

"At the conclusion of Week 12, the primary metric for success in this trial will be evaluated: A proportion of participants achieving Investigator's Global Assessment (IGA) score of 0 or 1 and a decrease from baseline by at least 2 points. Subsidiary objectives include Percent Change From Baseline (CFB) in EASI total score, Proportion of patients with reduction from baseline ≥4 point on weekly averages of PP-NRS, and Incidence of Increase in Local Tolerability Severity Grades."

Answered by AI

Who else is applying?

What state do they live in?
Texas
What site did they apply to?
Dermatology Treatment and Research Center
What portion of applicants met pre-screening criteria?
Met criteria
How many prior treatments have patients received?
3+

Why did patients apply to this trial?

I have had skin problems and was diagnosed with lupus and RA and possible celiac disease. This has been a problem for 3 years. Tried biologics and meds no help.
PatientReceived no prior treatments

How responsive is this trial?

Typically responds via
Email
Most responsive sites:
  1. Dermatology Treatment and Research Center: < 48 hours
Average response time
  • < 2 Days
Recent research and studies
clinicaltrials.govStudy
A Study to Learn About The Study Medicine (PF-07038124) In Patients With Mild To Moderate Atopic Dermatitis Or Mild To Severe Plaque Psoriasis.
2022. "A Study to Learn About The Study Medicine (PF-07038124) In Patients With Mild To Moderate Atopic Dermatitis Or Mild To Severe Plaque Psoriasis.". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05375955.
~102 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top